JPS6241208B2 - - Google Patents

Info

Publication number
JPS6241208B2
JPS6241208B2 JP51129605A JP12960576A JPS6241208B2 JP S6241208 B2 JPS6241208 B2 JP S6241208B2 JP 51129605 A JP51129605 A JP 51129605A JP 12960576 A JP12960576 A JP 12960576A JP S6241208 B2 JPS6241208 B2 JP S6241208B2
Authority
JP
Japan
Prior art keywords
patients
compound
symptoms
test
mood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP51129605A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5257333A (en
Inventor
Anton Fuitsushaa Korunerusen Kuruto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SANDO AG
Original Assignee
SANDO AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SANDO AG filed Critical SANDO AG
Publication of JPS5257333A publication Critical patent/JPS5257333A/ja
Publication of JPS6241208B2 publication Critical patent/JPS6241208B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP51129605A 1975-10-30 1976-10-29 Improvement in organic compound Granted JPS5257333A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4487875 1975-10-30

Publications (2)

Publication Number Publication Date
JPS5257333A JPS5257333A (en) 1977-05-11
JPS6241208B2 true JPS6241208B2 (2) 1987-09-02

Family

ID=10435089

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51129605A Granted JPS5257333A (en) 1975-10-30 1976-10-29 Improvement in organic compound

Country Status (2)

Country Link
US (1) US4085218A (2)
JP (1) JPS5257333A (2)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9811599D0 (en) 1998-05-30 1998-07-29 Glaxo Group Ltd Nitric oxide synthase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636717A (2) * 1962-08-31

Also Published As

Publication number Publication date
US4085218A (en) 1978-04-18
JPS5257333A (en) 1977-05-11

Similar Documents

Publication Publication Date Title
US6169105B1 (en) Potentiation of drug response
JP4925074B2 (ja) ミルタザピンと１種以上の選択的セロトニン再取り込み阻害剤とを含む医薬組成物
KR0164435B1 (ko) 비만증 치료용 약제학적 조성물
JP2003507435A (ja) 協力剤の組合せ物
EP2557921A1 (en) Methods for treatment of sleep-related breathing disorders
JP6196041B2 (ja) 大うつ病を有する患者において減量療法を提供する方法
JPS6143112A (ja) 精神性欲機能障害治療剤
JP2009543767A (ja) フリバンセリンとカフェインとを含む組成物、その調製方法及び薬剤としての使用
CA2003289C (en) Use of trifluoromethylphenyl-tetrahydropyridines for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders
JPH0635382B2 (ja) 抗不安薬としてのフルオキセチンの使用法
AU737590B2 (en) Use of mirtazapine for treating sleep apneas
CN1235545A (zh) 含有氯雷他定和减充血剂的用于治疗哮喘的组合物
JPH0667842B2 (ja) 基本的うつ病を軽減するためのうつ病治療剤
JP3159263B2 (ja) 薬 剤
US6498173B1 (en) Synergistic combination comprising roflumilast and a pde-3 inhibitor
JPH05509293A (ja) 不整脈および発作の治療における５―ｈｔ４受容体拮抗剤の使用
JPH07196493A (ja) 睡眠障害処置のためのメラトニン誘導体
JPS6133803B2 (2)
KR20000015805A (ko) 일산화질소 합성을 증가시키는 방법
JPH03170475A (ja) 抑うつ症治療剤
JPS6241208B2 (2)
JPS5823618A (ja) 精神分裂症を治療する組成物
WO2024102802A1 (en) Zelatriazin for the treatment of depression
JP2001504484A (ja) ネファゾドンの外傷後ストレス障害における使用
JP2002541190A (ja) 気分障害治療用医薬を製造するためのオサネタントの使用